
浏览全部资源
扫码关注微信
重庆医科大学附属儿童医院儿科研究所、国家儿童健康与疾病临床医学研究中心、儿童发育疾病研究教育部重点实验室、 重庆市干细胞治疗工程技术研究中心,重庆 400014
岳小涵,Email:987105944@qq.com,研究方向:骨肉瘤的恶性生物学行为、成骨分化以及能量代谢。
罗 庆,Email:352934430@qq.com。
收稿:2023-11-02,
修回:2024-03-13,
录用:2024-03-19,
纸质出版:2024-08-28
移动端阅览
岳小涵,康权,石雨鹭,等.过表达SIRT4对骨肉瘤细胞恶性生物学行为及能量代谢的影响[J].重庆医科大学学报,2024,49(8):949-958.
Yue Xiaohan,Kang Quan,Shi Yulu,et al.Effect of Sirtuin 4 overexpression on malignant biological behavior and energy metabolism of osteosarcoma cells[J].Journal of Chongqing Medical University,2024,49(8):949-958.
岳小涵,康权,石雨鹭,等.过表达SIRT4对骨肉瘤细胞恶性生物学行为及能量代谢的影响[J].重庆医科大学学报,2024,49(8):949-958. DOI: 10.13406/j.cnki.cyxb.003560.
Yue Xiaohan,Kang Quan,Shi Yulu,et al.Effect of Sirtuin 4 overexpression on malignant biological behavior and energy metabolism of osteosarcoma cells[J].Journal of Chongqing Medical University,2024,49(8):949-958. DOI: 10.13406/j.cnki.cyxb.003560.
目的
2
探讨过表达SIRT4对人骨肉瘤细胞恶性生物学行为及对成骨分化的调控作用,以及过表达SIRT4对线粒体能量代谢的影响。
方法
2
构建稳定过表达SIRT4的U2OS、MG63骨肉瘤细胞株,通过qRT-PCR和Western blot检测SIRT4的mRNA和蛋白表达水平;CCK-8、克隆形成实验、EDU555染色法及检测细胞增殖;裸鼠胫骨成瘤实验检验成瘤能力;流式细胞术检测细胞周期;DAPI染色及Annexin V-APC/7-AAD双染法检测细胞凋亡;细胞划痕实验、Transwell实验检测细胞迁移及侵袭能力;碱性磷酸酶(alkaline phosphatase,ALP)染色和茜素红S染色分别检测细胞的早期和晚期成骨分化;葡萄糖检测试剂盒测定培养基及细胞内葡萄糖含量;乳酸检测试剂盒测定培养基及细胞内乳酸含量;三磷酸腺苷(adenosine triphosphate,ATP)检测试剂盒检测细胞总ATP含量;四甲基罗丹明酯染色(tetramethylrhodamine ethylester perchlorate,TMRE)测定试剂检测线粒体膜电位。
结果
2
过表达SIRT4组细胞增殖、迁移及侵袭能力降低,裸鼠胫骨成瘤的瘤体体积减小,凋亡细胞增多;过表达SIRT4组细胞的G
0
/G
1
期占比明显增多,S期占比明显减少;过表达SIRT4组细胞ALP染色、茜素红S染色钙盐结节明显增多;过表达SIRT4组培养基中的葡萄糖较对照组消耗减少,细胞中的葡萄糖含量较对照组减少;过表达SIRT4组细胞中的乳酸含量较对照组减少,培养基中的乳酸较对照组产生减少;过表达SIRT4组细胞的总ATP较对照组更低;过表达SIRT4组的线粒体膜电位较对照组更低。
结论
2
在U2O和MG63细胞中,过表达SIRT4抑制骨肉瘤细胞增殖、迁移、侵袭以及成瘤能力,促进骨肉瘤细胞凋亡以及早晚期成骨分化,调节骨肉瘤细胞能量代谢。
Objective
2
To investigate the regulatory effect of sirtuin 4 (SIRT4) overexpression on the malignant biological behavior of human osteosarcoma cells and osteogenic differentiation,as well as the influence of SIRT4 overexpression on mitochondrial energy metabolism.
Methods
2
U2OS and MG63 osteosarcoma cell lines with stable overexpression of SIRT4 were constructed,and qRT-PCR and Western blot were used to measure the mRNA and protein expression levels of SIRT4;CCK-8 assay,colony formation assay,and EDU555 staining were used to observe cell proliferation;tibial tumorigenesis assay in nude mice was used to observe tumorigenic ability;flow cytometry was used to detect cell cycle;DAPI staining and Annexin V-APC/7-AAd double staining were used to measure cell apoptosis;wound healing assay and Transwell assay were used to observe the migration and invasion abilities of cells;alkaline phosphatase(ALP) staining and alizarin red S staining were used to detect early and late osteogenic differentiation,respectively;glucose assay kit was used to determine the content of glucose in the medium and cells;lactic acid assay kit was used to determine the content of lactic acid in the medium and cells;triphosphate assay kit was used to determine the total content of adenosine triphosphate(ATP) in the medium and cells;tetramethylrhodamine ethyl ester perchlorate staining was used to measure mitochondrial membrane potential.
Results
2
The SIRT4 overexpression group had significant reductions in the proliferation,migration,and invasion abilities of cells,a significant reduction in the tumor volume of tibial osteoblastoma in nude mice,and a significant increase in apoptotic cells. As for cell cycle,the SIRT4 overexpression group showed a significant increase in the proportion of cells in G
0
/G
1
phase and a significant reduction in the
proportion of cells in S phase. ALP staining and alizarin red S staining showed a significant increase in the number of calcium salt nodules in the SIRT4 overexpression group. Compared with the control group,the SIRT4 overexpression group had significant reductions in the consumption of glucose in the medium and the content of glucose in cells,as well as significant reductions in the content of lactic acid in cells and the medium. The SIRT4 overexpression group had a lower mitochondrial membrane potential than the control group.
Conclusion
2
In U2O and MG63 cells,SIRT4 overexpression inhibits the proliferation,migration,invasion,and tumorigenic ability of osteosarcoma cells,promotes the apoptosis of osteosarcoma cells and early and late osteogenic differentiation,and regulates energy metabolism in osteosarcoma cells.
Cho WH , Song WS , Jeon DG , et al . Differential presentations,clinical courses,and survivals of osteosarcomas of the proximal humerus over other extremity locations [J ] . Ann Surg Oncol , 2010 , 17 ( 3 ): 702 - 708 .
Cole S , Gianferante DM , Zhu B , et al . Osteosarcoma:a Surveillance,Epidemiology,and End Results program-based analysis from 1975 to 2017 [J ] . Cancer , 2022 , 128 ( 11 ): 2107 - 2118 .
Hanahan D , Weinberg RA . Hallmarks of cancer:the next generation [J ] . Cell , 2011 , 144 ( 5 ): 646 - 674 .
Zhu YM , Yan YF , Principe DR , et al . SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis [J ] . Cancer Metab , 2014 , 2 : 15 .
Haigis MC , Mostoslavsky R , Haigis KM , et al . SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells [J ] . Cell , 2006 , 126 ( 5 ): 941 - 954 .
Laurent G , German NJ , Saha AK , et al . SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase [J ] . Mol Cell , 2013 , 50 ( 5 ): 686 - 698 .
Huang GY , Cheng J , Yu FD , et al . Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer [J ] . Oncol Rep , 2016 , 35 ( 5 ): 2801 - 2810 .
Jeong SM , Xiao CY , Finley LW , et al . SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism [J ] . Cancer Cell , 2013 , 23 ( 4 ): 450 - 463 .
Wan W , Li YN , Zhou CY , et al . SIRT4 expression in laryngeal squamous cell carcinoma [J ] . Pharmazie , 2020 , 75 ( 12 ): 646 - 650 .
Jeong SM , Lee AN , Lee J , et al . SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma [J ] . J Biol Chem , 2014 , 289 ( 7 ): 4135 - 4144 .
Cai GH , Ge ZH , Xu YQ , et al . SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism [J ] . Sci Rep , 2022 , 12 ( 1 ): 12208 .
Zhu YY , Wang GY , Li XB , et al . Knockout of SIRT4 decreases chemosensitivity to 5-FU in colorectal cancer cells [J ] . Oncol Lett , 2018 , 16 ( 2 ): 1675 - 1681 .
Xing JL , Li J , Fu L , et al . SIRT4 enhances the sensitivity of ER-positive breast cancer to tamoxifen by inhibiting the IL-6/STAT3 signal pathway [J ] . Cancer Med , 2019 , 8 ( 16 ): 7086 - 7097 .
Delgrosso E , Scocozza F , Cansolino L , et al . 3D bioprinted osteosarcoma model for experimental boron neutron capture therapy (BNCT) applications:preliminary assessment [J ] . J Biomed Mater Res B Appl Biomater , 2023 , 111 ( 8 ): 1571 - 1580 .
Brown HK , Schiavone K , Gouin F , et al . Biology of bone sarcomas and new therapeuticdevelopments [J ] . Calcif Tissue Int , 2018 , 102 ( 2 ): 174 - 195 .
Dong ZH , Liao ZP , He YL , et al . Advances in the biological functions and mechanisms of miRNAs in the development of osteosarcoma [J ] . Technol Cancer Res Treat , 2022 , 21 : 15330338221117386 .
Xie DL , Wang ZQ , Li J , et al . Targeted delivery of chemotherapeutic agents for osteosarcoma treatment [J ] . Front Oncol , 2022 , 12 : 843345 .
Panez-Toro I , Muñoz-García J , Vargas-Franco JW , et al . Advances in osteosarcoma [J ] . Curr Osteoporos Rep , 2023 , 21 ( 4 ): 330 - 343 .
Huang H , Han Y , Chen ZJ , et al . ML264 inhibits osteosarcoma growth and metastasis via inhibition of JAK2/STAT3 and WNT/β-catenin signalling pathways [J ] . J Cell Mol Med , 2020 , 24 ( 10 ): 5652 - 5664 .
Zhu WT , Zeng XF , Yang H , et al . Resveratrol loaded by folate-modified liposomes inhibits osteosarcoma growth and lung metastasis via regulating JAK2/STAT3 pathway [J ] . Int J Nanomed , 2023 , 18 : 2677 - 2691 .
Wu W , Zhang ZH , Jing DD , et al . SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma [J ] . Cell Death Dis , 2022 , 13 ( 6 ): 523 .
Zhao S , Wang JM , Yan J , et al . BAG3 promotes autophagy and glutaminolysis via stabilizing glutaminase [J ] . Cell Death Dis , 2019 , 10 ( 4 ): 284 .
Yalçın GD , Colak M . SIRT4 prevents excitotoxicity via modulating glutamate metabolism in glioma cells [J ] . Hum Exp Toxicol , 2020 , 39 ( 7 ): 938 - 947 .
Cui Y , Bai YB , Yang JN , et al . SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/CyclinD1 pathway [J ] . Carcinogenesis , 2021 , 42 ( 3 ): 481 - 492 .
Hu QS , Qin Y , Ji SR , et al . UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer [J ] . Cancer Lett , 2019 , 452 : 226 - 236 .
Ping DN , Pu XF , Ding GP , et al . Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via deacetylation of the HRD1-SEL1L complex [J ] . Biochim Biophys Acta Gene Regul Mech , 2023 , 1866 ( 2 ): 194941 .
Wang YM , Guo YM , Gao JZ , et al . Tumor-suppressive function of SIRT4 in neuroblastoma through mitochondrial damage [J ] . Cancer Manag Res , 2018 , 10 : 5591 - 5603 .
仇 超 , 康 权 , 迭小红 , 等 . Id1基因对人骨肉瘤细胞恶性逆转向成骨分化的影响 [J ] . 第三军医大学学报 , 2016 , 38 ( 4 ): 344 - 349 .
Qiu C , Kang Q , Die XH , et al . Effect of Id1 gene on reversing malignant biological behaviors and inducing osteogenic differentiation of human osteosarcoma cells [J ] . J Third Mil Med Univ , 2016 , 38 ( 4 ): 344 - 349 .
Roschger C , Cabrele C . The Id-protein family in developmental and cancer-associated pathways [J ] . Cell Commun Signal , 2017 , 15 ( 1 ): 7 .
Singh SK , Singh S , Gadomski S , et al . Id1 ablation protects hematopoietic stem cells from stress-induced exhaustion and aging [J ] . Cell Stem Cell , 2018 , 23 ( 2 ): 252 - 265 .
Lin ZK , Liu Y , Xu T , et al . STAT3-mediated promoter-enhancer interaction up-regulates inhibitor of DNA binding 1( ID1 ) to promote colon cancer progression [J ] . Int J Mol Sci , 2023 , 24 ( 12 ): 10041 .
Sharma BK , Kolhe R , Black SM , et al . Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells [J ] . FASEB J , 2016 , 30 ( 1 ): 262 - 275 .
Xu X , Hou YQ , Lin SM , et al . Sodium selenite inhibits proliferation of lung cancer cells by inhibiting NF-κB nuclear translocation and down-regulating PDK1 expression which is a key enzyme in energy metabolism expression [J ] . J Trace Elem Med Biol , 2023 , 78 : 127147 .
Xing BY , Shen CY , Yang QL , et al . miR-144-3p represses hepatocellular carcinoma progression by affecting cell aerobic glycolysis via FOXK1 [J ] . Int J Exp Pathol , 2023 , 104 ( 3 ): 117 - 127 .
Kimura K , Chun JH , Lin YL , et al . Tetra -O-methyl-nordihy-droguaiaretic acid inhibits energy metabolism and synergistically induces anticancer effects with temozolomide on LN229 glioblastoma tumors implanted in mice while preventing obesity in normal mice that consume high-fat diets [J ] . PLoS One , 2023 , 18 ( 5 ): e0285536 .
Weng YP , Duan WH , Yu XC , et al . MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis [J ] . Cancer Sci , 2023 , 114 ( 6 ): 2345 - 2359 .
Mathias RA , Greco TM , Oberstein A , et al . Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity [J ] . Cell , 2014 , 159 ( 7 ): 1615 - 1625 .
0
浏览量
10
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621